At HotSpot, we are committed to building something we believe is truly distinctive, setting ourselves apart from our peers in...
Read moreEvery company has a culture, either by design or default. From our inception in 2016, we wanted to create a...
Read moreThe phrase ‘build it and they will come’ dates all the way back to the Old Testament, and in more...
Read moreHotSpot Therapeutics recently announced FDA clearance of our Investigational New Drug (IND) application for HST-1011, our small molecule allosteric inhibitor...
Read moreWhite Hat Hackers, sometimes called “ethical hackers,” are individuals that work to find and fix security problems in a system...
Read moreIt is in moments like this that we are reminded of the collective power of good to overcome the disenfranchised…
Read moreToday marks an important point in our journey to patients as HotSpot Therapeutics announces its $100MM Series C financing. This infusion of…
Read moreReturning to work following the pandemic presents an opportunity to think creatively about how to re-configure the workplace
Read moreToday marks an important milestone for HotSpot Therapeutics as we announce our Series B financing, but it also marks a...
Read moreThe conventional approach to drug discovery shines a light on specific target proteins, using an arsenal of biochemical and virtual...
Read more